# Histamine H3 Receptor Antagonists Influence the Directional Growth of Type II Spiral Ganglion Neurites Within the Developing Cochlea of C57BL/6 Mice

**Authors:** Lingyi Kong, Heidi Olze, Agnieszka J. Szczepek

PMC · DOI: 10.1007/s11064-025-04521-9 · 2025-08-13

## TL;DR

This study shows that blocking histamine H3 receptors in mouse cochleas affects the growth of specific nerve cells, suggesting a new role for these receptors in hearing development.

## Contribution

The study reveals a novel role for histamine H3 receptors in directing the growth of spiral ganglion neuron neurites in the developing cochlea.

## Key findings

- H3R mRNA levels are significantly higher in the modiolus compared to other cochlear regions.
- H3R antagonists disrupt type II spiral ganglion neurite projections, altering their growth direction.
- Ciproxifan causes hair cell loss, while pitolisant leads to stereociliary abnormalities at high concentrations.

## Abstract

The histamine H3 receptor (H3R) is a crucial regulator of synaptic plasticity, neurotransmitter release, and neural signaling within the central nervous system. However, its role in the cochlea remains poorly understood, even though mast cells, a rich endogenous source of histamine, have recently been documented in the mammalian cochlea. This study examined H3R expression and localization in the postnatal day 4–5 (P4-5) C57BL/6 mouse cochlea and evaluated its functional consequences under antagonist treatment. RT-qPCR analysis showed significantly higher H3R mRNA levels in the modiolus compared to the organ of Corti and the lateral wall. Immunofluorescence staining confirmed H3R localization in hair cells (HCs) and spiral ganglion neurons (SGNs). Dissected cochlear explants exposed to two distinct H3R antagonists—ciproxifan and pitolisant—at concentrations of 10µM, 50µM, and 100µM, displayed different responses: ciproxifan induced dose-dependent HC loss. In contrast, pitolisant caused no loss of HC but led to stereociliary abnormalities at higher concentrations. Both antagonists disrupted type II SGN neurite projections, redirecting their normal basal-directed trajectory toward the apical region. These findings implicate H3R in maintaining cochlear structural integrity and guiding SGN neurite development during early postnatal maturation. Further investigation into H3R-mediated mechanisms may reveal new therapeutic targets for hearing preservation and repair.

## Linked entities

- **Proteins:** H3R (transcriptional elongation factor)
- **Chemicals:** ciproxifan (PubChem CID 6422124), pitolisant (PubChem CID 9948102)

## Full-text entities

- **Genes:** Hrh3 (histamine receptor H3) [NCBI Gene 99296] {aka Eae8, H3R, HH3R}
- **Diseases:** stereociliary abnormalities (MESH:D000014), HC loss (MESH:D016388)
- **Chemicals:** histamine (MESH:D006632), ciproxifan (MESH:C115705), pitolisant (MESH:C516975)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12350512/full.md

---
Source: https://tomesphere.com/paper/PMC12350512